Tuesday, September 08, 2009 5:20:37 PM
ferryman - please. you whine and you whine and you whine, to what end? are you just trying to irritate everyone on this board with your droning on and on about dilution?
what purpose do you think you are serving?
geeze man....
what purpose do you think you are serving?
geeze man....
Recent XOMA News
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 03/18/2026 08:30:00 PM
- XOMA shares climb after Q4 results top forecasts on strong royalty income • IH Market News • 03/18/2026 02:14:34 PM
- XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements • GlobeNewswire Inc. • 03/18/2026 10:00:00 AM
- XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 • GlobeNewswire Inc. • 03/12/2026 10:30:00 AM
- XOMA Royalty to Present at Investor Conferences in March • GlobeNewswire Inc. • 02/18/2026 09:30:00 PM
- XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. • GlobeNewswire Inc. • 02/09/2026 02:53:00 PM
- XOMA Royalty Announces CFO Transition • GlobeNewswire Inc. • 01/12/2026 12:30:00 PM
- XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab • GlobeNewswire Inc. • 12/30/2025 12:30:00 PM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 12/22/2025 12:30:00 PM
- XOMA Royalty Enters into Agreement to Acquire Generation Bio • GlobeNewswire Inc. • 12/15/2025 10:00:00 PM
- XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc • GlobeNewswire Inc. • 12/05/2025 02:00:00 PM
- Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition • GlobeNewswire Inc. • 12/05/2025 12:45:00 PM
- Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty • GlobeNewswire Inc. • 11/26/2025 02:00:00 PM
- XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. • GlobeNewswire Inc. • 11/21/2025 12:45:00 PM
- XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements • GlobeNewswire Inc. • 11/12/2025 12:30:00 PM
- LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline • GlobeNewswire Inc. • 11/10/2025 09:09:25 PM
- Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty • GlobeNewswire Inc. • 10/24/2025 08:25:31 PM
- XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement • GlobeNewswire Inc. • 10/17/2025 03:45:00 PM
- XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V. • GlobeNewswire Inc. • 10/02/2025 08:43:26 PM
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics • PR Newswire (US) • 09/24/2025 10:00:00 AM
- ESSA Pharma Inc. Amends Agreement with XenoTherapeutics • PR Newswire (Canada) • 09/24/2025 10:00:00 AM
- XOMA Royalty Declares Quarterly Preferred Stock Dividends • GlobeNewswire Inc. • 09/22/2025 11:30:00 AM
- XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc. • GlobeNewswire Inc. • 09/17/2025 01:00:00 PM
- XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2025 11:30:00 AM
- Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share • GlobeNewswire Inc. • 08/20/2025 12:49:14 PM
